News

Thumbnail
Combined AI chatbot, telehealth app earns $25M investment

Physician-founded Counsel Health said it will use the funds to hire more doctors as it expands the userbase for its AI, which allows patients to ask questions and get answers from a real doctor.

approval regulations checkmark doctor
FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes

Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.

judge court gavel justice system legal
Judge blocks Trump's shutdown layoffs—1,200 HHS workers spared for now

U.S. District Court Judge Susan Illston said the firings appear to be politically motivated and may exceed the authority of the executive branch. She sided against the Trump administration, issuing a temporary restraining order to stop 4,200 federal employees from being fired. 

Positron emission tomography (PET) nuclear imaging has seen rapid expansion in cardiology and oncology due to its improve accuracy over SPECT and its ability to expand into new areas of cardiovascular imaging. A new review in the American Heart Association journal Stroke outlines another possible use of PET to assess carotid artery atherosclerosis for stroke prevention. Figure courtesy Stroke, https://www.ahajournals.org/doi/10.1161/STROKEAHA.125.050399
PET holds promise for carotid plaque assessments

PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.

heart data research doctor cardiologist AI
New-onset AFib is common after CABG—but typically not persistent or symptomatic

The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.

Thumbnail
Hospital in Mexico earns first heart failure certification of its kind

A facility outside the United States has received the American Heart Association's Comprehensive Heart Failure Center Certification for the first time.

patient experience
Healthcare AI today: Where’s the AI ROI?, AI messaging truth check, AI burnout busters, more

Provider organizations are using generative AI for all sorts of use cases. It’s delivering impressive returns in two—tech support and patient experience.

Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM

No medications are currently approved for the treatment of nonobstructive hypertrophic cardiomyopathy. Could a new drug from Imbria Pharmaceuticals be the first?

patient experience
Healthcare AI today: Where’s the AI ROI?, AI messaging truth check, AI burnout busters, more

Provider organizations are using generative AI for all sorts of use cases. It’s delivering impressive returns in two—tech support and patient experience.

Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM

No medications are currently approved for the treatment of nonobstructive hypertrophic cardiomyopathy. Could a new drug from Imbria Pharmaceuticals be the first?

Radiologists 'deeply concerned' about further tariffs on medical imaging devices

Last month, the Department of Commerce launched an investigation into the importing of such items, seeking to determine the impact on national security. 

FDA clears RadNet imaging AI solution for detecting neurodegenerative disease

Authorities granted 510(k) clearance for Brain Health in late September, with the Los Angeles-based imaging center operator touting the decision Tuesday. 

Around the web

Health Exec
Combined AI chatbot, telehealth app earns $25M investment

Physician-founded Counsel Health said it will use the funds to hire more doctors as it expands the userbase for its AI, which allows patients to ask questions and get answers from a real doctor.

Cardiovascular Business
FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes

Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.

Health Exec
Judge blocks Trump's shutdown layoffs—1,200 HHS workers spared for now

U.S. District Court Judge Susan Illston said the firings appear to be politically motivated and may exceed the authority of the executive branch. She sided against the Trump administration, issuing a temporary restraining order to stop 4,200 federal employees from being fired. 

Design by Adaptive Theme